Donor T cells lacking Fas ligand, and perforin retain the capacity to induce severe GvHD in minor histocompatibility antigen mismatched bone-marrow transplantation recipients

被引:21
|
作者
Marks, L
Altman, NH
Podack, ER
Levy, RB
机构
[1] Univ Miami, Sch Med, Dept Microbiol & Immunol, Miami, FL 33101 USA
[2] Univ Miami, Sch Med, Dept Pathol, Miami, FL 33101 USA
关键词
D O I
10.1097/01.TP.0000110416.96307.D5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Graft-versus-host disease (GvHD) is a frequent impediment to therapeutically successful allogeneic bone-marrow transplantation (BMT). This investigation further examines the roles of two potential donor cytotoxic effector mechanisms previously implicated in tissue pathogenesis. Cytotoxically double deficient (B6-cdd) T cells (lacking functional fas ligand and perforin) and wild-type (B6-wt) donor T-cell transplantation in a minor antigen-mismatched BMT model (C57BL/6 --> C3H.SW) resulted in similar mortality and weight loss. Histopathologic findings revealed mononuclear infiltrates and cellular atrophy in GvHD target tissues (liver, stomach) in recipients of B6-wt and B6-edd donor T cells. Both recipients also exhibited GvH-associated lymphohematopoietic compartment (LHC) alterations as evidenced by inverted CD4:CDS ratios and B-cell hypoplasia. Notably, transplants using recombinant inbred mHAg disparate recipients demonstrated that B6-cdd T cells induced lethal GvHD in CXBE but not CY-BG recipients: the same pattern induced by B6-wt T cells. This observation is consistent with previous findings that cytotoxic T lymphocyte (CTL) responses against CXBG and CXBE antigens did not correlate with GvH responses in these strains. In contrast with the typical pattern of donor T-cell expansion and contraction, T cells lacking perforin and FasH function exhibited extensive expansion postBMT. In summary, these findings support the notion that donor anti-host cytotoxicity by way of the two major pathways is not a prerequisite for induction of GvHD. In addition, the results suggest that this model will be useful to investigate the regulation of allogeneic donor T-cell expansion after major histocompatibility complex-matched allogeneic BMT.
引用
收藏
页码:804 / 812
页数:9
相关论文
共 24 条
  • [1] Fas ligand and perforin are not required for GVHD induction by CD8+ donor T cells in a class I/II mismatched BMT model.
    Jiang, Z
    Jones, M
    Levy, RB
    BLOOD, 2000, 96 (11) : 769A - 769A
  • [2] Regulatory CD8 T cells can fratricidally eliminate donor T cells utilizing Fas ligand and perforin following allogeneic bone marrow transplantation.
    Marks, L
    Levy, RB
    BLOOD, 2002, 100 (11) : 143A - 143A
  • [3] Major histocompatibility complex-mismatched allogeneic bone marrow transplantation using perforin and/or Fas ligand double-defective CD4+ donor T cells:: involvement of cytotoxic function by donor lymphocytes prior to graft-versus-host disease pathogenesis
    Jiang, Z
    Podack, E
    Levy, RB
    BLOOD, 2001, 98 (02) : 390 - 397
  • [4] MAJOR HISTOCOMPATIBILITY RESTRICTION OF ANTIGEN RECOGNITION BY T-CELLS IN A RECIPIENT OF HAPLOTYPE MISMATCHED HUMAN-BONE MARROW TRANSPLANTATION
    CHU, E
    UMETSU, D
    ROSEN, F
    GEHA, RS
    JOURNAL OF CLINICAL INVESTIGATION, 1983, 72 (03): : 1124 - 1129
  • [5] TOLERANCE OF ENGRAFTED DONOR T-CELLS FOLLOWING BONE-MARROW TRANSPLANTATION FOR SEVERE COMBINED IMMUNODEFICIENCY
    KEEVER, CA
    FLOMENBERG, N
    BROCHSTEIN, J
    SULLIVAN, M
    COLLINS, NH
    BURNS, J
    DUPONT, B
    OREILLY, RJ
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1988, 48 (03): : 261 - 276
  • [6] REDUCED LETHAL GRAFT VERSUS HOST-DISEASE (GVHD) USING CULTURED BONE-MARROW CELLS FOR TRANSPLANTATION ACROSS MINOR HISTOCOMPATIBILITY DIFFERENCES
    MAUCH, P
    LIPTON, JM
    HAMILTON, B
    HELLMAN, S
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 25 - 25
  • [7] Immunoregulatory aspects and role of donor NK and T cells after delayed donor leucocyte infusion in minor antigen mismatched bone marrow chimeras.
    Sefrioui, H
    Billiau, A
    Waer, M
    TRANSPLANTATION, 2000, 69 (08) : S281 - S281
  • [8] RECOGNITION OF CLONOGENIC LEUKEMIC-CELLS, REMISSION BONE-MARROW AND HLA-IDENTICAL DONOR BONE-MARROW BY CD8+ OR CD4+ MINOR HISTOCOMPATIBILITY ANTIGEN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES
    FABER, LM
    VANDERHOEVEN, J
    GOULMY, E
    OTTER, ALH
    VANLUXEMBURGHEIJS, SAP
    WILLEMZE, R
    FALKENBURG, JHF
    JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (02): : 877 - 883
  • [9] TOLERANCE TO HOST MINOR HISTOCOMPATIBILITY ANTIGENS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - SPECIFIC DONOR-HOST UNRESPONSIVENESS IS MAINTAINED BY PERIPHERAL TOLERIZING CELLS
    BROCHU, S
    ROY, DC
    PERREAULT, C
    JOURNAL OF IMMUNOLOGY, 1992, 149 (10): : 3135 - 3141
  • [10] Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways
    Zimmerman, Z
    Shatry, A
    Deyev, V
    Podack, E
    Mammolenti, M
    Blazar, BR
    Yagita, H
    Levy, RB
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (08) : 576 - 586